AI Autonomous Research Lab Coordination Platform LabSync Launches: Experiment Robots Run Drug Screening 24/7
Recursion Pharmaceuticals' LabSync platform enables autonomous coordination of multiple experiment robots, automating the full workflow from hypothesis generation to experiment execution, boosting drug screening efficiency 40-fold.
AI Autonomous Research Lab Coordination Platform LabSync Launches: Experiment Robots Run Drug Screening 24/7
On June 15, Recursion Pharmaceuticals released LabSync, an autonomous research laboratory coordination platform that achieves autonomous coordination and task allocation among multiple experiment robots for the first time. The platform can automatically plan experimental protocols based on AI-generated research hypotheses and coordinate 12 different types of experiment robots working around the clock on drug screening tasks.
In initial testing, LabSync completed in two weeks the volume of compound screening work that would traditionally take a laboratory 18 months, identifying three promising lead compounds. Recursion's Chief Science Officer said the platform will significantly accelerate rare disease drug development.
Four pharmaceutical companies have already signed trial agreements for LabSync.
Disclaimer
Content is AI-generated. Do not use it as a basis for real decisions. Do not cite it as factual reporting.